Well, yeah, in the first six months, actually seven. So. So. And I think we're going to continue to see those increase if we don't get in front of us. So I'm happy with the Schedule 1 on the three derivatives and I'm hoping we get the same result on the next on it's the seven. Oh, right. I think is the next one. So any other questions on topic, Director Baines? It seems almost like some of this stuff is whack a mole. Yeah. (24:27–24:35)
CLAIM
Expresses satisfaction with the Schedule 1 classification of three derivatives and hopes for similar classification of additional substances.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
_(cropped).jpg)